• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综述:新型冠状病毒(COVID-19)的流行病学、发病机制与疫苗研发前景。

A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19).

机构信息

Department of Biotechnology, Radha Govind University, Ramgarh, 829122 Jharkhand, India.

出版信息

Indian J Tuberc. 2021 Jan;68(1):92-98. doi: 10.1016/j.ijtb.2020.09.021. Epub 2020 Sep 28.

DOI:10.1016/j.ijtb.2020.09.021
PMID:33641858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7521210/
Abstract

In December 2019, a large number of coronavirus cases were emerged in Wuhan, Hubei Province, China and rapidly spread to different countries and territories around the world within four months. The World Health Organization (WHO) declared this outbreak as a global health emergency. The spread of COVID-19 over globe is highly contagious; they transmitted from person-to-person through small droplets of infected person. Many diagnosis and treatment methods have been implemented to reduce and control the outbreak. Efforts have been made to develop coronavirus vaccine against S protein or spike glycoprotein of coronavirus. COVID-19 outbreak will affect the Gross Domestic Product (GDP) of the world. At the time of preparing manuscript, total number of active cases reaches to more than 8.9 million and confirmed death reaches to approx. 4.6 lakh. This article highlights the ongoing research and advances in designing vaccine and therapeutics against COVID-19 and also focusing on the epidemiology, transmission, future direction and control the spread of infectious diseases.

摘要

2019 年 12 月,中国湖北省武汉市出现了大量的冠状病毒病例,并在四个月内迅速传播到世界各地的不同国家和地区。世界卫生组织(WHO)宣布此次疫情为全球卫生紧急事件。COVID-19 在全球范围内高度传染性;它们通过感染者的小飞沫在人与人之间传播。已经实施了许多诊断和治疗方法来减少和控制疫情。人们一直在努力开发针对冠状病毒 S 蛋白或刺突糖蛋白的冠状病毒疫苗。COVID-19 疫情将影响世界国内生产总值(GDP)。在撰写本文时,活跃病例总数已超过 890 万,确诊死亡人数约为 46 万。本文重点介绍了针对 COVID-19 设计疫苗和治疗方法的正在进行的研究和进展,并侧重于传染病的流行病学、传播、未来方向和控制传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f4/7521210/a84f618138ae/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f4/7521210/7c4e9dffdf18/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f4/7521210/ff36bd3389ce/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f4/7521210/a84f618138ae/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f4/7521210/7c4e9dffdf18/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f4/7521210/ff36bd3389ce/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10f4/7521210/a84f618138ae/gr3_lrg.jpg

相似文献

1
A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19).综述:新型冠状病毒(COVID-19)的流行病学、发病机制与疫苗研发前景。
Indian J Tuberc. 2021 Jan;68(1):92-98. doi: 10.1016/j.ijtb.2020.09.021. Epub 2020 Sep 28.
2
The Perspective of Coronavirus Disease Outbreak: Epidemiology, Transmission, and Possible Treatment.新型冠状病毒肺炎的研究进展:流行病学、传播途径及可能的治疗方法。
Vector Borne Zoonotic Dis. 2021 Feb;21(2):78-85. doi: 10.1089/vbz.2020.2678. Epub 2020 Dec 14.
3
Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.新型冠状病毒的治疗措施:现状与未来展望综述。
Curr Mol Med. 2021;21(7):562-572. doi: 10.2174/1566524020666201203170230.
4
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.COVID-19,一种新兴的冠状病毒感染:在疫苗、免疫疗法和治疗药物的设计和开发方面的进展和前景。
Hum Vaccin Immunother. 2020 Jun 2;16(6):1232-1238. doi: 10.1080/21645515.2020.1735227. Epub 2020 Mar 18.
5
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
6
Insights into Novel Coronavirus Disease 2019 (COVID-19): Current Understanding, Research, and Therapeutic Updates.对 2019 年新型冠状病毒病(COVID-19)的深入了解:当前的认识、研究和治疗进展。
Recent Pat Biotechnol. 2022;16(1):35-63. doi: 10.2174/1872208315666210805152122.
7
COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management.COVID-19 大流行:从起源到结局。对病毒发病机制、临床表现、诊断评估和治疗的全面综述。
Infez Med. 2021 Mar 1;29(1):20-36.
8
Convalescent Plasma Therapy against COVID-19: An Update on the Changing Facets of the ongoing Pandemic.恢复期血浆疗法治疗 COVID-19:正在进行的大流行中不断变化的方面的最新进展。
Curr Pharm Biotechnol. 2023;24(12):1515-1523. doi: 10.2174/1389201024666230202144314.
9
Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies.新型冠状病毒:从起源到治疗策略现状的综述。
Crit Rev Eukaryot Gene Expr. 2021;31(3):21-34. doi: 10.1615/CritRevEukaryotGeneExpr.2021038075.
10
SARS-CoV2 Outbreak: Emergence, transmission and clinical features of human coronaviruses.SARS-CoV2 爆发:人冠状病毒的出现、传播和临床特征。
J Ayub Med Coll Abbottabad. 2020 Oct-Dec;32(Suppl 1)(4):S710-S713.

本文引用的文献

1
Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020.2020 年印度针对 2019 年冠状病毒病的严重急性呼吸道疾病监测。
Indian J Med Res. 2020;151(2 & 3):236-240. doi: 10.4103/ijmr.IJMR_1035_20.
2
Convalescent plasma transfusion for the treatment of COVID-19: Systematic review.恢复期血浆输注治疗 COVID-19:系统评价。
J Med Virol. 2020 Sep;92(9):1475-1483. doi: 10.1002/jmv.25961. Epub 2020 May 12.
3
Molecular immune pathogenesis and diagnosis of COVID-19.新型冠状病毒肺炎的分子免疫发病机制与诊断
J Pharm Anal. 2020 Apr;10(2):102-108. doi: 10.1016/j.jpha.2020.03.001. Epub 2020 Mar 5.
4
The COVID-19 vaccine development landscape.2019冠状病毒病疫苗的研发情况。
Nat Rev Drug Discov. 2020 May;19(5):305-306. doi: 10.1038/d41573-020-00073-5.
5
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.严重急性呼吸综合征冠状病毒 2 特异性抗体反应在冠状病毒疾病患者中。
Emerg Infect Dis. 2020 Jul;26(7):1478-1488. doi: 10.3201/eid2607.200841. Epub 2020 Jun 21.
6
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.恢复期血浆疗法治疗重症 COVID-19 患者的疗效。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.
7
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.氯喹和羟氯喹在治疗伴有或不伴有糖尿病的2019冠状病毒病中的应用:一项系统检索及叙述性综述,特别提及印度和其他发展中国家
Diabetes Metab Syndr. 2020 May-Jun;14(3):241-246. doi: 10.1016/j.dsx.2020.03.011. Epub 2020 Mar 26.
8
COVID-19: faecal-oral transmission?新冠病毒:粪口传播?
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):259. doi: 10.1038/s41575-020-0295-7.
9
Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients.新型冠状病毒病 2019(COVID-19):919 例患者影像学表现的系统评价。
AJR Am J Roentgenol. 2020 Jul;215(1):87-93. doi: 10.2214/AJR.20.23034. Epub 2020 Mar 14.
10
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.无症状携带者状态、急性呼吸道疾病和严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的肺炎:事实与误区。
J Microbiol Immunol Infect. 2020 Jun;53(3):404-412. doi: 10.1016/j.jmii.2020.02.012. Epub 2020 Mar 4.